Amarin Corporation plc (ADR) Share Price Xetra
Equities
EH3A
US0231112063
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
||
0.653 EUR | 0.00% |
Sales 2024 * | 202M 188M 16.87B | Sales 2025 * | 215M 200M 17.93B | Capitalization | 284M 264M 23.67B |
---|---|---|---|---|---|
Net income 2024 * | -70M -65.22M -5.84B | Net income 2025 * | -64M -59.63M -5.34B | EV / Sales 2024 * | 1.19 x |
Net cash position 2024 * | 43.92M 40.92M 3.67B | Net cash position 2025 * | 159M 148M 13.24B | EV / Sales 2025 * | 0.58 x |
P/E ratio 2024 * |
-3.91
x | P/E ratio 2025 * |
-4.15
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.48% |
Latest transcript on Amarin Corporation plc (ADR)
Managers | Title | Age | Since |
---|---|---|---|
Aaron Berg
CEO | Chief Executive Officer | 61 | 01/12/01 |
Thomas Reilly
DFI | Director of Finance/CFO | 52 | 20/22/20 |
Compliance Officer | 55 | 15/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Louis Sterling
BRD | Director/Board Member | 45 | 28/23/28 |
Odysseas Kostas
CHM | Chairman | 49 | 28/23/28 |
Keith Horn
BRD | Director/Board Member | 66 | 28/23/28 |
1st Jan change | Capi. | |
---|---|---|
+15.19% | 121B | |
+19.91% | 114B | |
+18.37% | 23.61B | |
-19.80% | 20.43B | |
-15.73% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+66.67% | 15.19B | |
+2.13% | 13.54B |
- Stock Market
- Equities
- AMRN Stock
- EH3A Stock